Patents by Inventor Elisa Eiseman

Elisa Eiseman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5859017
    Abstract: In a method for treating or preventing allergy or allergic disorders an effective amount of a compound that inhibits intracellular generation of phosphatidic acid and diacylglycerol is administered. The intracellular generation of phosphatidic acid and diacylglycerol results from allergen presentation or mast cell/basophil activation.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: January 12, 1999
    Assignee: Cell Therapeutics, Inc.
    Inventors: Elisa Eiseman, Emer Clarke, Jack W. Singer, Stuart L. Bursten
  • Patent number: 5521315
    Abstract: There is disclosed an olefin-substituted compound having the formula:R--(core moiety),wherein R is a straignt chain hydrocarbon having at least one double bond and a carbon chain length of from about 6 to about 18 carbon atoms, wherein multiple double bonds are separated from each other by at least three carbon atoms, wherein the closest double bond to the core moiety is at least five carbon atoms from the core moiety, and wherein the hydrocarbon chain may be substituted by a hydroxyl, halo, keto or dimethylanimo group and/or interrupted by an oxygen atom and salts thereof and pharmaceutical compositions thereof.
    Type: Grant
    Filed: May 10, 1993
    Date of Patent: May 28, 1996
    Assignee: Cell Therapeutics, Inc.
    Inventors: Gail Underiner, David Porubek, J. Peter Klein, Elisa Eiseman, Alistair Leigh, Anil Kumar, John Michnick